- Home
- QGEN vs PSO Comparison
QGEN vs PSO Comparison
Compare QGEN & PSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- PSO
- Stock Information
- Founded
- QGEN 1986
- PSO 1844
- Country
- QGEN Netherlands
- PSO United Kingdom
- Employees
- QGEN N/A
- PSO 17116
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- PSO Books
- Sector
- QGEN Health Care
- PSO Consumer Discretionary
- Exchange
- QGEN Nasdaq
- PSO Nasdaq
- Market Cap
- QGEN 9.1B
- PSO 9.5B
- IPO Year
- QGEN 1996
- PSO 2000
- Fundamental
- Price
- QGEN $48.08
- PSO $14.38
- Analyst Decision
- QGEN Buy
- PSO
- Analyst Count
- QGEN 8
- PSO 0
- Target Price
- QGEN $50.68
- PSO N/A
- AVG Volume (30 Days)
- QGEN 1.3M
- PSO 705.7K
- Earning Date
- QGEN 08-05-2025
- PSO 01-01-0001
- Dividend Yield
- QGEN 3.14%
- PSO 2.21%
- EPS Growth
- QGEN N/A
- PSO 20.49
- EPS
- QGEN 0.42
- PSO 0.79
- Revenue
- QGEN $2,002,874,000.00
- PSO $4,446,837,010.00
- Revenue This Year
- QGEN $6.36
- PSO $3.66
- Revenue Next Year
- QGEN $6.18
- PSO $3.94
- P/E Ratio
- QGEN $115.46
- PSO $17.18
- Revenue Growth
- QGEN 3.31
- PSO N/A
- 52 Week Low
- QGEN $37.63
- PSO $12.90
- 52 Week High
- QGEN $48.90
- PSO $17.90
- Technical
- Relative Strength Index (RSI)
- QGEN 59.71
- PSO 37.08
- Support Level
- QGEN $47.25
- PSO $14.36
- Resistance Level
- QGEN $48.90
- PSO $14.91
- Average True Range (ATR)
- QGEN 0.81
- PSO 0.17
- MACD
- QGEN -0.12
- PSO 0.01
- Stochastic Oscillator
- QGEN 68.98
- PSO 24.24
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About PSO Pearson Plc
Pearson PLC listed in the U.K., is an educational provider. The company has been divesting non-core businesses such as the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider. While Pearson's primary activity centers on higher education, the firm also operates in providing clinical assessments, professional certification, and testing.